Agentic AI in healthcare is moving beyond answering prompts. It now handles complex marketing tasks on its own. Life sciences companies are starting to build their commercial strategies around this shift.
A recent report cited by Capgemini Invent states that AI agents could create up to $450 billion in global economic value by 2028. The report links this value to higher revenue and lower costs. It also shows that 69 percent of executives plan to use AI agents in marketing by the end of the year.
Pharmaceutical marketing faces especially high pressure. Sales representatives now get less face time with healthcare professionals. Covid-19 accelerated this change. The real challenge goes beyond access. Sales teams must make every interaction count. Today, important insights remain locked inside disconnected data systems.
The fragmented intelligence problem
Briggs Davidson, senior director of digital, data, and marketing strategy for life sciences at Capgemini Invent, describes a common situation in pharma marketing. A healthcare professional attends a conference. A competitor presents strong drug results. The HCP publishes new research. The HCP then shifts prescriptions to a competing product, all within one quarter.
Most companies store this information across multiple systems. CRM tools, event platforms, and claims databases all hold different pieces of the story. Legacy IT systems and data silos prevent teams from seeing the full picture. Sales representatives usually lack access to this information before meeting the HCP.
Davidson explains that companies do not need to simply connect systems. They need to deploy agentic AI in healthcare marketing. These systems can search, combine, and act on unified data on their own. Conversational AI only responds to questions. Agentic AI completes multi-step tasks independently.
An AI agent can replace manual data work. The agent can query CRM and claims databases directly. It can answer questions such as identifying oncologists in the Northwest with a 20 percent drop in prescriptions who attended the last medical congress.
From coordination to autonomous execution
Davidson describes a shift from an omnichannel view to true orchestration. Omnichannel focuses on coordinating channels. Agentic AI focuses on taking action.
Sales representatives can use AI agents to plan calls and visits. They can ask which messages an HCP engaged with most recently. They can request a detailed intelligence brief before a meeting.
The agentic system gathers key insights, including:
- Recent conversations with the HCP
- Prescribing behavior
- Thought leaders the HCP follows
- Relevant content to share
- Preferred communication channels such as in-person visits, email, or webinars
The AI agent then builds a personalized call plan for each HCP. It also recommends next steps based on engagement results. Davidson explains that agentic AI drives action instead of just answering prompts.
This shift also changes how sales teams think. Sales representatives move from asking questions to managing small teams of AI agents. One agent plans outreach. Another agent retrieves and checks content. A third agent schedules and measures activity. A fourth agent enforces compliance rules. Humans remain in control at every step.
The AI-ready data requirement
This approach depends on AI-ready data. Teams must standardize data and keep it accessible, complete, and trustworthy. This foundation enables three key outcomes.
- Faster decision-making helps sales teams act early. Predictive analytics deliver near real-time alerts about upcoming changes.
- Personalization at scale allows small teams to serve thousands of HCPs. Specialized AI agents make this possible.
- Clear marketing ROI replaces backward-looking reports. Teams can see which marketing activities actually drive prescriptions.
Davidson stresses the need for alignment between marketing and IT teams. Leaders must agree on early use cases. Teams must also define KPIs that show real impact, such as higher HCP engagement or better sales productivity.
Critical implementation questions
The article positions agentic AI in healthcare as a new operating layer for commercial teams. It also notes that companies only see full value when they prepare data, deploy systems responsibly, and redesign workflows.
The article does not fully address regulatory and compliance challenges. Autonomous systems may access claims data that includes prescriber behavior. Companies must follow strict rules such as HIPAA’s minimum necessary standard.
The article also lacks real client examples or performance metrics. It mainly references the projected $450 billion opportunity.
Davidson notes that global organizations should tailor use cases to each market. Regulatory maturity differs by region. Deployment strategies must reflect these differences.
The core value remains simple. Healthcare professionals receive relevant and timely content. Marketing teams improve engagement and conversion.
The industry now faces a clear test. Life sciences companies must overcome data governance and compliance barriers. Their success or failure will decide whether they can reach anything close to the projected $450 billion opportunity by 2028.